Last updated: 2026-09-24
Forearm light shows glucose range — no needle, no phone — Tutorial
A small forearm patch can show whether your glucose is in range with a colored light — without a needle to place it and without needing a phone — and can also track how meals, movement, and sleep relate to that range. Placement can feel like a stamp instead of a shot. The patch itself can show in-range with colored light — phone optional — and can relate meals, movement, and sleep to that range. Honest limits stay in the lesson: not an insulin tool, clocks still exist, and shelf-access news is not inventing a brand.
| Page | Title | Concept (one line) | When the tutor offers it | Illustration |
|---|---|---|---|---|
| 01 | Needle-free placement | Stamp-like placement on the inner forearm — no hypodermic needle for insertion. | First beat, before the sensor mechanism. | 01 |
| 02 | Skin-deep sensors read glucose range | Tiny intradermal sensors read sugar in skin fluid as a semi-quantitative range. | After needle-free friction; before the on-patch light one idea. | 02 |
| 03 | On-patch light — no phone required | A small forearm patch can show whether your glucose is in range with a colored light — without a needle to place it and without needing a phone — and can also track how meals, movement, and sleep relate to that range. | Core one idea after sensors; before daily-life multi-signal. | 03 |
| 04 | Meals, movement, and sleep join the story | Activity and sleep sit next to range so meals, walks, and rest become a story. | After the one idea; before shelf-access path. | 04 |
| 05 | From prescription path to shelf access | De Novo created the type (Rx); company OTC announce expands access — K-number unresolved. | After multi-signal; before honest limits. | 05 |
| 06 | Honest limits | Not insulin / not hypo-alarm for high-risk; ~2h warm-up; ~5-day wear; adults 22+ not on insulin. | After shelf path; before invent. | 06 |
| 07 | Invent an everyday change at Glowreach | Invent a useful everyday way. Leave the design open. No brand. | Last page / invent gate. | 07 |
Sources
- FDA De Novo decision summary / Accessdata classification record — Class II glucose range monitoring system; intradermal microsensor array; on-patch LED ranges; accelerometer + ambient light; ~2-hour start; ~5-day wear; adults 22+ not on insulin; Rx on original grant (decision Sep 2025)
- FDA device description language — interstitial glucose range via oxidase amperometry; standalone on-body lights; lifestyle / behavioral awareness with clinician consultation; labeled contraindications and interferents
- Company / wire public announce of FDA 510(k) clearance for over-the-counter use of a needle-free wearable tracking glucose, activity, and sleep (24 Sep 2026; org self-report)
- Company site — needle-free placement claims; blue = target range teaching language; activity and sleep integration (org self-report)
- Explicit unresolved at authorship time — OTC 510(k) number not published in Accessdata results retrieved 24 Sep 2026; do not invent a K-number